Skip to search formSkip to main contentSkip to account menu

rhenium-186 HEDP

Known as: (186Re)-hydroxyethylidene diphosphonate, Re 186 Hydroxyethylidene Diphosphonate, rhenium-186 hydroxyethylidene diphosphonate 
An synthetic compound containing the organic phosphonate hydroxyethylidene diphosphonate (HEDP) labeled with the radioisotope rhenium Re 186. Re-186… 
National Institutes of Health

Related topics

Related topics

6 relations
Etidronate DisodiumNCIt Antineoplastic Agent Terminology

Broader (3)

Etidronic AcidOrganometallic Compoundsrhenium

Narrower (1)

rhenium-188 HEDP

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Rhenium fac tricarbonyl bisimine complexes: biologically useful fluorochromes for cell imaging applications.
A series of lipophilic and hydrophilic fac tricarbonyl rhenium bisimine complexes have been prepared, their membrane… 
Highly Cited
2003
Highly Cited
2003
Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
PURPOSE We investigated the effect of repeated bone-targeted therapy with rhenium-188 hydroxyethylidenediphosphonate (HEDP) in… 
Highly Cited
2003
Highly Cited
2003
Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases.
UNLABELLED 188Re-Hydroxyethylidene diphosphonate ((188)Re-HEDP) was used in previous studies for the palliative treatment of… 
Highly Cited
2001
Highly Cited
2001
Rhenium-188 HEDP To Treat Painful Bone Metastases
Purpose Rhenium-188 hydroxyethylidine diphosphonate (HEDP) is a new and attractive radiopharmaceutical that localizes in skeletal… 
Highly Cited
2000
Highly Cited
2000
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
Abstract.The aim of this study was to determine the maximum tolerated dose of rhenium-188 hydroxyethylidene diphosphonate (HEDP… 
2000
2000
Comparison of Rhenium-188, Rhenium-186-HEDP and Strontium-89 in palliation of painful bone metastases
Summary Aim: Several radiopharmaceuticals were compared previously with regard to the efficiency in pain palliation of bone… 
Highly Cited
1996
Highly Cited
1996
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.
UNLABELLED Rhenium-186-1,1-hydroxyethylidene diphosphonate (186Re-HEDP) has been used for the palliative treatment of metastatic… 
Highly Cited
1996
Highly Cited
1996
Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain.
UNLABELLED Rhenium-186-etidronate has been developed for pain relief of bone metastases and has previously been studied with… 
Highly Cited
1991
Highly Cited
1991
Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
Rhenium-186 (tin) hydroxyethylidene diphosphonate (HEDP) is a new radiopharmaceutical that simultaneously localizes in multiple… 
Highly Cited
1973
Highly Cited
1973
The influence of multidentate organic phosphonates on the crystal growth of hydroxyapatite
The rate of crystal growth of hydroxyapatite seed crystals in stable supersaturated solutions of calcium phosphate has been… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)